Article
Diacylglycerol acyltransferase-1 (DGAT1) inhibition perturbs postprandial gut hormone release.
PloS one - 1 Jan 2013
Lin Hua V, Chen Dunlu, Shen Zhu, Zhu Lei, Ouyang Xuesong, Vongs Aurawan, Kan Yanqing, Levorse John M, Kowalik Edward J, Szeto Daphne M, Yao Xiaorui, Xiao Jianying, Chen Shirley, Liu Jinqi, Garcia-Calvo Marga, Shin Myung K, Pinto Shirly
Abstract excerpt
Diacylglycerol acyltransferase-1 (DGAT1) is a potential therapeutic target for treatment of obesity and related metabolic diseases. However, the degree of DGAT1 inhibition required for metabolic benefits is unclear. Here we show that partial DGAT1 deficiency in mice suppressed postprandial triglyceridemia, led to elevations in glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) only following meals with very...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
